1. Home
  2. CLLS vs PBPB Comparison

CLLS vs PBPB Comparison

Compare CLLS & PBPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • PBPB
  • Stock Information
  • Founded
  • CLLS 1999
  • PBPB 1977
  • Country
  • CLLS France
  • PBPB United States
  • Employees
  • CLLS N/A
  • PBPB N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • PBPB Restaurants
  • Sector
  • CLLS Health Care
  • PBPB Consumer Discretionary
  • Exchange
  • CLLS Nasdaq
  • PBPB Nasdaq
  • Market Cap
  • CLLS 299.0M
  • PBPB 516.4M
  • IPO Year
  • CLLS 2007
  • PBPB 2013
  • Fundamental
  • Price
  • CLLS $3.56
  • PBPB $17.13
  • Analyst Decision
  • CLLS Buy
  • PBPB Buy
  • Analyst Count
  • CLLS 1
  • PBPB 3
  • Target Price
  • CLLS $8.00
  • PBPB $17.37
  • AVG Volume (30 Days)
  • CLLS 221.6K
  • PBPB 557.0K
  • Earning Date
  • CLLS 11-03-2025
  • PBPB 11-06-2025
  • Dividend Yield
  • CLLS N/A
  • PBPB N/A
  • EPS Growth
  • CLLS N/A
  • PBPB N/A
  • EPS
  • CLLS N/A
  • PBPB 0.35
  • Revenue
  • CLLS $63,438,000.00
  • PBPB $469,138,000.00
  • Revenue This Year
  • CLLS N/A
  • PBPB $5.24
  • Revenue Next Year
  • CLLS $66.76
  • PBPB $4.70
  • P/E Ratio
  • CLLS N/A
  • PBPB $49.43
  • Revenue Growth
  • CLLS 223.09
  • PBPB N/A
  • 52 Week Low
  • CLLS $1.10
  • PBPB $7.27
  • 52 Week High
  • CLLS $5.48
  • PBPB $17.13
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 48.40
  • PBPB 81.91
  • Support Level
  • CLLS $3.93
  • PBPB $17.05
  • Resistance Level
  • CLLS $5.48
  • PBPB $17.07
  • Average True Range (ATR)
  • CLLS 0.38
  • PBPB 0.02
  • MACD
  • CLLS -0.07
  • PBPB -0.13
  • Stochastic Oscillator
  • CLLS 9.44
  • PBPB 100.00

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

About PBPB Potbelly Corporation

Potbelly Corp owns and franchises hundreds of limited-service restaurants specializing in sandwiches and salads, shakes. The menu includes toasty sandwiches, signature salads, soups, chili, sides, desserts, and, in breakfast locations it serves breakfast sandwiches and steel-cut oatmeal. majority of its locations are company-owned and located in the United States, with Illinois and Texas housing far more locations than any other state. The company has franchise partners in a number of countries. Excluding the United States, its franchises are in the Middle East.

Share on Social Networks: